These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
869 related articles for article (PubMed ID: 17545861)
1. Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis. Tahamiler R; Saritzali G; Canakcioglu S Laryngoscope; 2007 Jun; 117(6):965-9. PubMed ID: 17545861 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the long-term efficacy of subcutaneous and sublingual immunotherapies in perennial rhinitis. Tahamiler R; Saritzali G; Canakcioglu S; Ozcora E; Dirican A ORL J Otorhinolaryngol Relat Spec; 2008; 70(3):144-50. PubMed ID: 18391573 [TBL] [Abstract][Full Text] [Related]
3. Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy. Tonnel AB; Scherpereel A; Douay B; Mellin B; Leprince D; Goldstein N; Delecluse P; Andre C Allergy; 2004 May; 59(5):491-7. PubMed ID: 15080829 [TBL] [Abstract][Full Text] [Related]
4. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial. Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432 [TBL] [Abstract][Full Text] [Related]
5. [Analysis of the efficacy of specific immunotherapy with house-dust mite extracts in adults with allergic rhinitis and/or asthma]. Polzehl D; Keck T; Riechelmann H Laryngorhinootologie; 2003 Apr; 82(4):272-80. PubMed ID: 12717603 [TBL] [Abstract][Full Text] [Related]
6. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures. Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799 [TBL] [Abstract][Full Text] [Related]
7. Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study. Yukselen A; Kendirli SG; Yilmaz M; Altintas DU; Karakoc GB Int Arch Allergy Immunol; 2012; 157(3):288-98. PubMed ID: 22041501 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study. Tari MG; Mancino M; Monti G Allergol Immunopathol (Madr); 1990; 18(5):277-84. PubMed ID: 2097894 [TBL] [Abstract][Full Text] [Related]
9. Nasal ECP patterns and specific immunotherapy in mite-allergic rhinitis patients. Ferreira MB; Santos AS; Santos MC; Carlos ML; Barbosa MA; Carlos AG Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):96-102. PubMed ID: 15918296 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of sublingual immunotherapy in Asian children. Park IH; Hong SM; Lee HM Int J Pediatr Otorhinolaryngol; 2012 Dec; 76(12):1761-6. PubMed ID: 22959336 [TBL] [Abstract][Full Text] [Related]
12. Absence of IgE neosensitization in house dust mite allergic patients following sublingual immunotherapy. Baron-Bodo V; Batard T; Nguyen H; Fréreux M; Horiot S; Harwanegg C; Bergmann KC; de Beaumont O; Moingeon P Clin Exp Allergy; 2012 Oct; 42(10):1510-8. PubMed ID: 22994348 [TBL] [Abstract][Full Text] [Related]
13. Fast onset of action of sublingual immunotherapy in house dust mite-induced allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial. Wang DH; Chen L; Cheng L; Li KN; Yuan H; Lu JH; Li H Laryngoscope; 2013 Jun; 123(6):1334-40. PubMed ID: 23616386 [TBL] [Abstract][Full Text] [Related]
14. Randomized double-blind controlled study with sublingual carbamylated allergoid immunotherapy in mild rhinitis due to mites. Passalacqua G; Pasquali M; Ariano R; Lombardi C; Giardini A; Baiardini I; Majani G; Falagiani P; Bruno M; Canonica GW Allergy; 2006 Jul; 61(7):849-54. PubMed ID: 16792583 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma--a placebo controlled study. Mungan D; Misirligil Z; Gürbüz L Ann Allergy Asthma Immunol; 1999 May; 82(5):485-90. PubMed ID: 10353581 [TBL] [Abstract][Full Text] [Related]
16. A comparative study of the clinical efficacy of immunotherapy and conventional pharmacological treatment for patients with perennial allergic rhinitis. Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Washio Y; Yamada K; Sakamoto H; Nasako Y; Hayashi M; Nakai Y Acta Otolaryngol Suppl; 1998; 538():102-12. PubMed ID: 9879409 [TBL] [Abstract][Full Text] [Related]
17. Three-year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing sub-lingual immunotherapy. Marcucci F; Sensi L; Di Cara G; Salvatori S; Bernini M; Pecora S; Burastero SE Pediatr Allergy Immunol; 2005 Sep; 16(6):519-26. PubMed ID: 16176400 [TBL] [Abstract][Full Text] [Related]
18. [The results of extra diagnostic methods in patients allergic to dust mites treated by specific immunotherapy]. Modrzyński M; Mazurek H; Zawisza E Przegl Lek; 2005; 62(12):1337-42. PubMed ID: 16786743 [TBL] [Abstract][Full Text] [Related]
19. [Observation on the effect of the dust mite sublingual immunotherapy for allergic rhinitis]. Du X; Shu C; Xu G; Ma M; Song H Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Apr; 26(8):372-3. PubMed ID: 22730824 [TBL] [Abstract][Full Text] [Related]
20. Long-lasting effects of sublingual immunotherapy for house dust mites in allergic rhinitis with bronchial hyperreactivity: A long-term (13-year) retrospective study in real life. Marogna M; Bruno M; Massolo A; Falagiani P Int Arch Allergy Immunol; 2007; 142(1):70-8. PubMed ID: 17016060 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]